Agency for Medicinal Products and Medical Devices of the Republic of Slovenia
The European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) are updating recommendations on booster doses of mRNA COVID-19 vaccines. Due to current wave of …
JAZMP is ambitious to further actively participate in assessment of marketing authorisation applications. In order to strengthen Slovenia’s position in the regulatory EU environment, one of the strategic objectives of …
JAZMP AVAILABLE TO ACT AS REFERENCE MEMBER STATE (RMS) IN MRP AND DCP PROCEDURES Read More »
The first paragraph of article 152 of Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC …
On 23 and 24 November 2021 the Agency of the Republic of Slovenia for Medicinal Products and Medical Devices (JAZMP) will host and chair the second plenary meeting of the …
The United Kingdom (UK) submitted on 29 March 2017 the notification of its intention to withdraw from the Union pursuant to Article 50 of the Treaty on European Union. Following …
Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (JAZMP) calls again on the Marketing Authorisation Holders to provide information about product codes (PC) used in unique …
Call on marketing authorisation holders to provide information about product codes (PC) Read More »
The stabilisation period in Slovenia, introduced after the implementation of Commission Delegated Regulation 2016/161, ended on 1st of December 2019. Therefore the Agency for Medicinal Products and Medical Devices of …
Call on marketing authorisation holders to provide information about product codes (PC) Read More »
